Dawnrays Pharmaceutical (Holdings) Balance Sheet Health
Financial Health criteria checks 5/6
Dawnrays Pharmaceutical (Holdings) has a total shareholder equity of CN¥2.9B and total debt of CN¥120.1M, which brings its debt-to-equity ratio to 4.2%. Its total assets and total liabilities are CN¥3.6B and CN¥763.4M respectively. Dawnrays Pharmaceutical (Holdings)'s EBIT is CN¥276.0M making its interest coverage ratio -10.8. It has cash and short-term investments of CN¥1.2B.
Key information
4.2%
Debt to equity ratio
CN¥120.06m
Debt
| Interest coverage ratio | -10.8x |
| Cash | CN¥1.17b |
| Equity | CN¥2.86b |
| Total liabilities | CN¥763.43m |
| Total assets | CN¥3.62b |
Recent financial health updates
Recent updates
Dawnrays Pharmaceutical (Holdings) (HKG:2348) Will Pay A Dividend Of CN¥0.065
Apr 22
Dawnrays Pharmaceutical (Holdings) (HKG:2348) Has Announced A Dividend Of CN¥0.065
Apr 08Dawnrays Pharmaceutical (Holdings) (HKG:2348) Is Due To Pay A Dividend Of CN¥0.065
Mar 25Dawnrays Pharmaceutical (Holdings) (HKG:2348) Has Announced A Dividend Of CN¥0.015
Aug 30Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Shareholders Will Receive A Bigger Dividend Than Last Year
May 26Dawnrays Pharmaceutical (Holdings) (HKG:2348) Will Pay A Dividend Of CN¥0.073
Apr 04Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be CN¥0.015
Sep 19Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Solid Profits Have Weak Fundamentals
Sep 22Dawnrays Pharmaceutical (Holdings) (HKG:2348) Will Pay A Dividend Of HK$0.015
Sep 12Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be HK$0.015
Aug 29Here's How We Evaluate Dawnrays Pharmaceutical (Holdings) Limited's (HKG:2348) Dividend
Feb 28Would Shareholders Who Purchased Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Stock Five Years Be Happy With The Share price Today?
Feb 07
Yung Lai Hung Is The Co-Founder & Executive Director of Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348) And They Just Picked Up 34% More Shares
Jan 14Dawnrays Pharmaceutical (Holdings) Limited's (HKG:2348) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Dec 22What Kind Of Investors Own Most Of Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)?
Dec 09Three Things You Should Check Before Buying Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348) For Its Dividend
Nov 23Financial Position Analysis
Short Term Liabilities: 2348's short term assets (CN¥1.7B) exceed its short term liabilities (CN¥668.9M).
Long Term Liabilities: 2348's short term assets (CN¥1.7B) exceed its long term liabilities (CN¥94.5M).
Debt to Equity History and Analysis
Debt Level: 2348 has more cash than its total debt.
Reducing Debt: 2348's debt to equity ratio has increased from 0% to 4.2% over the past 5 years.
Debt Coverage: 2348's debt is well covered by operating cash flow (281.9%).
Interest Coverage: 2348 earns more interest than it pays, so coverage of interest payments is not a concern.